Literature DB >> 1964578

The effect of clonidine on hormone release mediated through activation of opiate receptors.

B Baranowska1.   

Abstract

To elucidate the mechanism of clonidine's effect on hormone release, serum growth hormone (GH), luteinizing hormone (LH), cortisol, and plasma beta-endorphin concentrations were determined after clonidine, naloxone, or the combined therapy of clonidine plus naloxone in six healthy women investigated in the luteal phase of their menstrual cycles. The clonidine injection increased GH levels. Naloxone (0.05, 0.1, and 0.2 mg/kg) decreased serum GH concentrations. Naloxone also increased serum LH, whereas clonidine decreased LH levels. Only the maximal dose of naloxone significantly increased serum cortisol concentrations. Clonidine had opposite effects on cortisol levels. These results demonstrate that combined therapy with clonidine plus naloxone leads to inhibition of the response of GH, LH, and cortisol to clonidine injection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1964578     DOI: 10.1007/bf01856507

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  25 in total

Review 1.  Comparison of pharmacokinetics and pharmacodynamics of adrenoceptor agonists and antagonists as antihypertensive agents.

Authors:  W J Louis; J J McNeil; S N Anavekar; E L Conway; B Workman; L G Howes; O H Drummer; B Jarrott
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

Review 2.  The structure and evolution of adrenergic and muscarinic cholinergic receptors.

Authors:  J C Venter
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

Review 3.  Stress, central neurotransmitters, and the mechanism of action of alpha 2-adrenoceptor agonists.

Authors:  T H Svensson
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

Review 4.  Alpha-adrenoceptor subclassification.

Authors:  K Starke
Journal:  Rev Physiol Biochem Pharmacol       Date:  1981       Impact factor: 5.545

Review 5.  The neuroendocrinology of opioid peptides.

Authors:  A Grossman; L H Rees
Journal:  Br Med Bull       Date:  1983-01       Impact factor: 4.291

6.  Endocrine effects of naloxone-induced opiate receptor blockade.

Authors:  J E Morley; N G Baranetsky; T D Wingert; H E Carlson; J M Hershman; S Melmed; S R Levin; K R Jamison; R Weitzman; R J Chang; A A Varner
Journal:  J Clin Endocrinol Metab       Date:  1980-02       Impact factor: 5.958

7.  Inhibition of adrenergic neurotransmission by clonidine: an action on prejunctional -receptors.

Authors:  K Starke; K P Altmann
Journal:  Neuropharmacology       Date:  1973-04       Impact factor: 5.250

8.  The role of opiate, dopaminergic, and adrenergic systems in the hypothalamo-pituitary dysfunction in obesity.

Authors:  B Baranowska; S P Singh; P Soszynski; J Nowakowski; W Jeske
Journal:  Acta Endocrinol (Copenh)       Date:  1987-10

9.  Normalization of blood pressure and plasma concentrations of beta-endorphin and leucine-enkephalin in patients with primary hypertension after treatment with clonidine.

Authors:  K Kraft; R Theobald; R Kolloch; K O Stumpe
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

10.  Do alpha-adrenergic mechanisms regulate spontaneous or opiate-modulated pulsatile luteinizing hormone secretion in man?

Authors:  J D Veldhuis; A D Rogol; F A Williams; M L Johnson
Journal:  J Clin Endocrinol Metab       Date:  1983-12       Impact factor: 5.958

View more
  1 in total

Review 1.  Drugs and HPA axis.

Authors:  Alberto Giacinto Ambrogio; Francesca Pecori Giraldi; Francesco Cavagnini
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.